Company / Profit Margin
CAPRICOR THERAPEUTICS, INC. Profit Margin History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-181.7%
FY2024
5-year range
-8175.9% / -88.5%
FY2020-FY2024
Trend
-105.3%
vs FY2023
Sector context
#108 of 146
Health Care
What the data says
At -181.7%, CAPRICOR THERAPEUTICS, INC.'s profit margin ranks #108 of 146 in the Health Care sector. Profit Margin has fluctuated over the past 9 years, ranging from -8175.9% in FY2021 to 91.2% in FY2017.
Based on SEC 10-K filings.
-181.7% in FY2024 with a 5-year CAGR of +727.2%.
Improved from -1137.4% to -181.7% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +7994.2pp
- 5-Year Change
- +727.2pp
- 10-Year Change
- -
Sector benchmark
#108 of 146 in Health CareTop 74% of 146This company -181.7% Sector average -796.3%
▼
+77.2% above sector average
Key checks
Key Insights
- In FY2024, profit margin decreased 105.3% year-over-year.
- Currently 614.6pp above the Health Care sector average.
- Peak profit margin was recorded in FY2017.
- Lowest profit margin in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -181.7% | -105.3% |
| FY2023 | -88.5% | +92.2% |
| FY2022 | -1137.4% | +86.1% |
| FY2021 | -8175.9% | -85.7% |
| FY2020 | -4401.9% | -384.3% |
| FY2019 | -908.9% | +0.0% |
| FY2018 | -908.9% | -1096.7% |
| FY2017 | 91.2% | +119.4% |
| FY2016 | -470.3% | -101.8% |
As of FY2024 · SEC 10-K · Updated Jul 4, 2026